Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MySkin Vitiligo is a topical herbal formulation marketed for the treatment of vitiligo and leukoderma. The product is typically composed of a blend of traditional medicinal plant extracts, most notably *Psoralea corylifolia* (Bakuchi), which is rich in psoralens. These compounds act as photosensitizers that, upon exposure to ultraviolet (UV) light, intercalate into the DNA of melanocytes to stimulate their proliferation and melanin synthesis. The formulation is designed to restore natural skin pigmentation by activating dormant melanocytes in the basal layer of the epidermis. While widely available as an alternative or complementary therapy, it is distinct from regulated pharmaceutical interventions and autologous cell therapies used for similar indications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MySkin Vitiligo.